Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   New flow cytometric assays for monitoring cell-mediated cytotoxicity
  2. Zaritskaya, L.; Shurin, M. R.; Sayers, T. J.; Malyguine, A. M.
  3. Expert Review of Vaccines. 2010, Jun; 9(6): 601-616.
  1. 2.   Application of a Flow Cytometric Cytotoxicity Assay for Monitoring Cancer Vaccine Trials
  2. Zaritskaya, L.; Shafer-Weaver, K. A.; Gregory, M. K.; Strobl, S. L.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2009 32(2): 186-194.
  1. 3.   A novel flow cytometric assay for evaluating cell-mediated cytotoxicity
  2. Burkett, M. W.; Weaver, K. A. S.; Strobl, S.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, JUL-AUG; 28(4): 396-402.
  1. 4.   Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays
  2. Wallace, D.; Hildesheim, A.; Pinto, L. A.
  3. Clinical and Diagnostic Laboratory Immunology. 2004 11(2): 255-260.
  1. 5.   Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
  2. Kamohara, H.; Matsuyama, W.; Shimozato, O.; Abe, K.; Galligan, C.; Hashimoto, S. I.; Matsushima, K.; Yoshimura, T.
  3. Immunology. 2004 111(2): 186-194.
  1. 6.   Study of diverse mechanisms of cell-mediated cytotoxicity in gene-targeted mice using flow cytometric cytotoxicity assay
  2. Malyguine, A.; Derby, E.; Brooks, A.; Reddy, V.; Baseler, M.; Sayers, T.
  3. Immunology Letters. 2002 83(1): 55-59.
  1. 7.   Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity
  2. Derby, E.; Reddy, V.; Kopp, W.; Nelson, E.; Baseler, M.; Sayers, T.; Malyguine, A.
  3. Immunology Letters. 2001 78(1): 35-39.
  1. 8.   IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy
  2. Wigginton, J. M.; Gruys, E.; Geiselhart, L.; Subleski, J.; Komschlies, K. L.; Park, J. W.; Wiltrout, T. A.; Nagashima, K.; Back, T. C.; Wiltrout, R. H.
  3. Journal of Clinical Investigation. 2001 108(1): 51-62.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel